Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

NCT07458659 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma (MM)

Interventions

BIOLOGICAL: Chimeric Antigen Receptor T Cells (CAR-T)

Sponsor

Chulalongkorn University

Collaborators

[object Object]